{
    "code": "01021955",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01021955",
    "time": "2016-01-15 04:11:10",
    "許可證字號": "衛署藥製字第021955號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/05\/25",
    "發證日期": "69\/08\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102195502",
    "中文品名": "\"生達\"痛止注射液（奧菲那特林）",
    "英文品名": "TONSTOP INJECTION  \"STANDARD\"(ORPHENADRINE)",
    "適應症": "因動脈硬化或特發性引起之震顫癱瘓、因腦炎後引起之帕金森樣疾病",
    "劑型": "270注射劑",
    "包裝": "1.2公撮10,100,120安瓿盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "ORPHENADRINE CITRATE",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "0510620200  生達化學製藥股份有限公司",
    "申請商地址": "台南市新營區土庫里土庫6之20號",
    "主製造廠": {
        "製造廠名稱": "0510620300  生達化學製藥股份有限公司",
        "製造廠廠址": "台南市新營區土庫里土庫6之20號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003420",
            "成分名稱": "ORPHENADRINE CITRATE",
            "含量描述": "30",
            "含量": "30.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010219550001-103-02-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01021955&Seq=001&Type=9"
        }
    ]
}